Institutional
Aquamarine Financial (Cayman) Ltd
CIK 0002104187
$1.37B
Reported AUM
17
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Aquamarine Financial (Cayman) Ltd · Q1 2026
AI · grounded in 13F
Aquamarine Financial (Cayman) Ltd established a new position in SCO valued at $28.29M. The fund also opened new stakes in NU for $14.37M and DRTS for $5.1M. Additionally, the manager accumulated shares of INVZ, increasing the position by 2,820.43%. These moves come as the fund expanded its portfolio to 17 positions.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | BBD | BANCO BRADESCO S A | $588.7M | 43.11% | +8,177,336 | +5.5% |
| 2 | YPF | YPF SOCIEDAD ANONIMA | $417.2M | 30.55% | -1,465,882 | -14.0% |
| 3 | GGAL | GRUPO FINANCIERO GALICIA S.A | $110.7M | 8.10% | +268,673 | +12.8% |
| 4 | GGB | GERDAU SA | $60.4M | 4.42% | -2,800,000 | -14.3% |
| 5 | BSBR | BANCO SANTANDER BRASIL S A | $58.2M | 4.26% | +47,603 | +0.5% |
| 6 | BMA | BANCO MACRO SA | $41.2M | 3.02% | -32,011 | -5.7% |
| 7 | SCO | PROSHARES TR II | $28.3M | 2.07% | +3,400,000 | NEW |
| 8 | BBAR | BANCO BBVA ARGENTINA S A | $19.8M | 1.45% | +94,017 | +8.2% |
| 9 | NU | NU HLDGS LTD | $14.4M | 1.05% | +1,000,000 | NEW |
| 10 | CSAN | COSAN S A | $8.6M | 0.63% | — | HELD |
| 11 | ORMP | ORAMED PHARMACEUTICALS INC | $7.2M | 0.53% | +139,255 | +7.1% |
| 12 | DRTS | ALPHA TAU MEDICAL LTD | $5.1M | 0.37% | +721,501 | NEW |
| 13 | INVZ | INNOVIZ TECHNOLOGIES LTD | $3.3M | 0.24% | +5,000,000 | +2820.4% |
| 14 | — | PULSENMORE LTD | $1.2M | 0.09% | +338,541 | NEW |
| 15 | TGS | TRANSPORTADORA DE GAS DEL SU | $1.0M | 0.08% | — | HELD |
| 16 | CEPU | CENTRAL PUERTO S A | $325K | 0.02% | — | HELD |
| 17 | VLN/WS | VALENS SEMICONDUCTOR LTD | $15K | 0.00% | — | HELD |
Source: SEC EDGAR · accession 0001493152-26-023398. 13F discloses long positions only — shorts, foreign equities, and options are excluded.